A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Experts with the Cleveland Clinic say the drug has a lot of potential, especially since it is considered nonaddictive.

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain for adults.

On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...

It’s become a familiar tragedy: someone is prescribed pain medication to recover from an injury, then becomes addicted to the ...

Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

新泽西州罗斯兰 - 市值1.01亿美元的先进药物输送仪器开发商Milestone Scientific Inc. (NYSE: MLSS)宣布在领先的疼痛管理诊所Advanced Spine and Pain Management商业推出其CompuFlo®硬膜外麻醉系统。这一进展是在与Varinder ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex ...